Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
25.60
-0.97 (-3.65%)
At close: Oct 17, 2025, 4:00 PM EDT
25.03
-0.57 (-2.23%)
After-hours: Oct 17, 2025, 4:42 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.25 billion as of October 17, 2025. Its market cap has increased by 440.31% in one year.
Market Cap
1.25B
Enterprise Value
1.28B
1-Year Change
440.31%
Ranking
Category
Stock Price
$25.60
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $1.25B, an increase of 401.78%. That is a compound annual growth rate of 19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.25B | 744.95% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | 581.15M | 179.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |